a key role in the development of liver cancer caused by these chemicals. For example, their potency as carcinogens has been Previous studies demonstrated that dietary glycine prevents associated with their ability to sustain cell proliferation. WYelevated rates of cell proliferation following treatment with 14,643, one of the most potent carcinogens in this class, the peroxisome proliferator and liver carcinogen WYincreased cell proliferation for as long as the compound 14,643. Since increased cell replication is associated with was administered while the much less potent carcinogen the development of hepatic cancer caused by peroxisome diethylhexyl phthalate did not, even at doses 12-fold higher proliferators, glycine may have anti-cancer properties.
(3). Elevated rates of hepatocyte replication may be important Therefore, experiments were designed to test the hypothesis in the promotion of previously initiated cells, which are more that dietary glycine would inhibit the hepatocarcinogenic numerous in older than younger rats, and may explain why effect of WY-14,643. Male F344 rats were fed four different peroxisome proliferators cause a greater number of preneo-NIH 07-based diets: 5% glycine; 5% valine for nitrogen plastic lesions in livers of older rats (4,5). Thus, it has been balance (control); 0.1% WY-14,643 ⍣ 5% valine (WYproposed that peroxisome proliferators act as tumor promoters
14,643); 0.1% WY-14,643 ⍣ 5% glycine (WY-14,643 ⍣ by stimulating proliferation of previously initiated cells (3). glycine). Food consumption did not differ among the
Since Kupffer cells, the resident hepatic macrophages, are groups, but WY-14,643-fed rats weighed 10-25% less than a rich source of mitogenic stimuli in the liver (6), it was expected based on previous studies. Serum glycine levels hypothesized that peroxisome proliferators activate Kupffer were elevated 4-5-fold by glycine-containing diets; however, cells to release cytokines that stimulate cell replication in the the 10-fold increase in peroxisomal enzyme activity caused liver. In support of this hypothesis, WY-14,643 was shown to by WY-14,643 was unaffected by the addition of 5% glycine activate the production of the hepatocyte mitogen tumor to the diet. After 22 weeks, livers from rats fed WY-14, 643 necrosis factor α (TNFα) which is produced predominantly had a similar incidence and multiplicity of proliferative by Kupffer cells in liver (7). Moreover, antibodies to TNFα lesions (foci and adenomas) to those fed WY-14,643 ⍣ prevented WY-14,643-induced cell proliferation (7). Furtherglycine. Moreover, cell proliferation in the surrounding more, inactivation of Kupffer cells with methyl palmitate 'normal' parenchyma (labeling index ≈ 4%) and foci prevented TNFα production and cell proliferation in response (labeling index ≈ 50%) did not differ between WY-14,643
to WY-14,643 (8). Since inactivation of Kupffer cells with and WY-14,643 ⍣ glycine-fed rats. However, after 51 methyl palmitate requires daily i.v. injections, long-term studies weeks of dietary exposure to WY-14,643, glycine prevented are not practical. Therefore, a dietary method of Kupffer cell formation of small (0-5 mm diameter) tumors by 23% and inactivation was employed. A glycine-enriched diet prevented inhibited the development of medium size (5-10 mm) both the initial increase in cell proliferation 24 h after a single tumors by 64%. Furthermore, glycine prevented the formadose and the sustained elevation caused by WY-14,643-induced tion of the largest tumors (>10 mm) by nearly 80%. Thus, TNFα production after 3 weeks of dietary treatment (9). glycine did not inhibit early foci formation; however, it Therefore, these studies were designed to test the hypothesis significantly decreased their ability to progress to tumors.
that dietary glycine would prevent the development of preneoMoreover, the inhibitory effect of glycine was greater with plastic foci and tumors caused by long-term dietary exposure increasing tumor size. These studies demonstrate that to WY-14,643. Preliminary accounts of this work have been dietary glycine prevents the development of hepatic tumors presented elsewhere (10). caused by the peroxisome proliferator WY-14,643 consistentIntroduction housed two per cage in biologically clean rooms with filtered air and a 12 h day/night cycle. Animals were quarantined for 2 weeks upon arrival and WY-14,643 is a member of the class of compounds known as maintained on NIH-07 chow and purified water ad libitum. Temperature and peroxisome proliferators, which include a wide variety of relative humidity were held at 22 Ϯ 2°C and 50 Ϯ 5%, respectively. Treated structurally unrelated chemicals that increase both the number animals were given the same rodent chow blended with WY-14,643 (ChemSyn Science Laboratories, Lenexa, KS) at a target concentration of 0.1%. The concentration of WY-14,643 in the feed was assayed after each blending and Abbreviation: TNFα, tumor necrosis factor α. Base diet for all treatments was NIH 07 chow. Glycine was added at 5% (w/w) or valine was used in controls as a nitrogen balance. WY-14,643 was added at 0.1% (w/w) as described in Materials and methods.
the measured values were within 20% of the target concentration. Glycine or valine (as a nitrogen balance) were added to the same rodent chow at a target concentration of 5% (Table I ). Seven days prior to the 22 week killing, Alzet osmotic pumps (Palo Alto, CA; flow rate10 µl/h) containing 16 mg/ml 5-bromo-2Ј-deoxyuridine (BrdU; Sigma) were implanted s.c. in six rats per group. Food consumption and body weights were monitored weekly throughout the study.
Histopathology and immunohistochemistry
After 22 weeks (six animals per group) or 51 weeks (10-14 animals per group) on diets, rats were killed by exsanguination under pentobarbital anesthesia. At the time of necropsy, terminal body weights and liver wet weights were recorded. Liver sections were made for hematoxylin and eosin, and immunohistochemical staining for BrdU and proliferating cell nuclear antigen (PCNA). Incorporation of BrdU was determined as described elsewhere (11). A section of ileum was included from each rat as a positive control for BrdU incorporation. Labeled and unlabeled hepatocyte nuclei were counted in randomly generated, high-power (400ϫ) fields of tissue sections from preneoplastic foci or tissue sections from 'normal' surrounding parenchyma. At least 1000 hepatocyte nuclei were counted per rat to calculate the percentage Fig. 1 . Effect of glycine and WY-14,643 on body weight. Body weights of labeled nuclei (labeling index). In animals not given osmotic pumps were measured weekly for the first 10 weeks and every 2 weeks thereafter. containing BrdU (51 week animals), labeling index was determined using *, Statistical differences from both the control and glycine groups (repeated antibodies to PCNA. The percentage of labeled nuclei was determined in measures ANOVA with Student-Newman-Keuls post-hoc tests; P Ͻ 0.05, tumors and in normal parenchyma as described for BrdU incorporation above.
n ϭ 14-20 in each group). At the 22 week time point, grossly visible lesions on the liver surface were sized and quantitated. At the 51 week time point, livers were sectioned at 1-2 mm intervals for quantification of grossly observable lesions. Frozen and formalin-fixed sections of lesions were collected for histological evaluation.
Table II. Serum glycine concentration Enzyme assays
Serum glycine concentration (µM) Liver from the left lobe was used to prepare 20% homogenates in 50 mM Tris-HCl, 154 mM KCl, pH 7.2. Samples were kept on ice until freezing at 22 weeks 51 weeks -80°C. The post-nuclear supernatant of the thawed liver homogenate was prepared on the day of enzyme assays by centrifugation at 2500 g for 10 min.
Control 172 Ϯ 15 162 Ϯ 34 Acyl CoA oxidase activity was assayed by measurement of hydrogen peroxide Glycine 790 Ϯ 50 a,b 644 Ϯ 19 a,b production in the presence of 25 µM palmitoyl-CoA (12) . Enzyme activity WY-14,643 289 Ϯ 20 488 Ϯ 38 a was normalized per g of protein (13) .
WY-14,643 ϩ glycine 860 Ϯ 50 a,b 726 Ϯ 31 a,b Measurement of serum glycine levels Blood was harvested by cardiac puncture for glycine determination in serum Blood glycine levels were measured as described in Materials and methods. as described previously (14) . Briefly, glycine was extracted, benzoylated Data are reported as means Ϯ SEM. and the resulting hippuric acid was extracted and dried. Subsequently, the a Statistical difference from control. concentration of hippuric acid was determined spectrophotometrically at 458 b Statistical difference from WY-14,643 (P Ͻ 0.05, ANOVA with Tukey's nm (15) .
post-hoc tests, n ϭ 4 in each group).
Results

long-term feeding studies with WY-14,643 (3,9). Reasons for Effects of WY-14,643 and dietary glycine on body and liver
this phenomenon remain unknown. The glycine-containing weights, serum glycine concentration, and induction of peroxdiets increased serum glycine levels 4-5-fold after 22 weeks isomes of feeding (Table II) consistent with results from other studies (16) . Interestingly, WY-14,643 alone caused an almost 2-fold Food consumption (w/w) did not differ among the four dietary groups studied (data not shown). However, body weights of increase in serum glycine levels for reasons that also remain unknown (Table II) . both WY-14,643 and WY-14,643 ϩ glycine-fed rats were significantly lower than control and glycine-fed rats between Both WY-14,643 and the WY-14,643 ϩ glycine diets increased liver weights~70% over the control and glycine 4 and 51 weeks, as expected (Figure 1 ). Rats on WY-14,643 or WY-14,643 ϩ glycine diets weighed from 10 to 25% less groups after 22 weeks of feeding ( Figure 2A ). After 51 weeks, livers from control and glycine-fed animals weighed~13 g than those on control or glycine diets alone. This effect of WY-14,643 on body weight confirms results obtained in other while WY-14,643 increased liver weight significantly to~30 g A defining characteristic of all peroxisome proliferators is an induction of peroxisome-specific enzymes such as acyl CoA oxidase (1). Following 22 weeks of dietary treatment, WY-14,643 increased peroxisomal acyl CoA oxidase activitỹ 10-fold over control values, an increase which was unaffected by dietary glycine (Figure 3 ). The increases in peroxisomal enzymes measured in these studies are similar to those reported in previous chronic feeding studies with WY-14,643 (3).
Effects of WY-14,643 and dietary glycine on preneoplastic foci and cell proliferation following 22 weeks of treatment
At time of death, visible lesions (preneoplastic foci) on the liver surface were sized and counted. As expected, no foci were detected in livers from rats fed control and glycine diet alone (data not shown). However, WY-14,643 treatment led to formation of preneoplastic foci that were separated into three categories based on size: Ͻ1 mm diameter, 1-2 mm diameter or Ͼ4 mm diameter (Table III) . WY-14,643 fed at Furthermore, lesions Ͼ4 mm in diameter were rare (Table III) .
Cell proliferation was assessed using incorporation of BrdU in both foci and the surrounding parenchyma at 22 weeks. In (Figure 2B ). Although the WY-14,643 ϩ glycine-fed animals had livers which also weighed more than controls, they were the surrounding liver tissue, rates of cell proliferation in control and glycine-fed rats were generally Ͻ1%, rates that were significantly smaller than livers from rats fed WY-14,643 alone ( Figure 2B ).
increased~4-fold by WY-14,643 (Table IV) . The increase in cell proliferation caused by WY-14,643 at 22 weeks was The initial 8-fold burst in cell replication and the sustained 5-unaffected by the addition of 5% glycine to the diet (Table  fold increase following 3 weeks of dietary treatment were both  IV) . Similarly, proliferation rates in preneoplastic foci from prevented by the addition of 5% glycine to the diet (9). Since rats fed WY-14,643 did not differ from those in the WYhepatocyte replication has been hypothesized to play a key 14,643 ϩ glycine group at this time point (Table IV) . Rates of role in peroxisome proliferator-induced liver cancer (3), these proliferation in foci were much higher than in the surrounding studies were designed to determine if dietary glycine would parenchyma as demonstrated in previous studies (17) .
prevent WY-14,643-induced hepatic cancer in rodents. The addition of 0.1% WY-14,643 to the diet suppressed Effect of dietary glycine on WY-14,643-induced tumor weight gain compared with rats fed control diet (Figure 1 ). formation While this phenomenon has been observed in several longAfter 51 weeks on diets, animals were killed and tumors term feeding studies with peroxisome proliferators, the cause identified. Rats on control and glycine diets did not have liver remains unknown (3,9). One possibility is that TNFα, which tumors as expected (data not shown). However, WY-14,643 is also known as cachectic factor and is responsible for the caused tumors of varying sizes in all rats (Figure 4) . Tumors wasting phenomenon in cancer patients, plays a role since were sized and placed into the following groups: 0-5 mm WY-14,643 causes a 2-3-fold increase in TNFα in liver (7). diameter, 5-10 mm diameter, Ͼ10 mm diameter. WY-14,643
Importantly, glycine had no effect on body weight gain in caused an average of nearly 32 tumors per liver of 0-5 mm these studies (Figure 1 ). diameter which was reduced significantly by the addition of Feeding glycine at 5% in the diet resulted in a 4-5-fold 5% glycine to the diet ( Figure 4A ). Only about four tumors increase in blood glycine levels (Table II) . While glycineper liver of 5-10 mm were found in WY-14,643-treated rats supplemented diet increased blood glycine levels, the absolute and glycine reduced this value~3-fold ( Figure 4B ). The concentration was not as high as the nearly 1.5 mM levels addition of 5% glycine to the diet also caused a significant obtained in previous studies (16) . Although the exact reason reduction in the number of tumors Ͼ10 mm in diameter is unknown, several possibilities exist. First, other studies with ( Figure 4C ). Interestingly, the inhibitory effect of dietary dietary glycine were for shorter periods of time (e.g. 3 days glycine was greater as the tumor size increased ( Figure 5 ). It to 4 weeks) than the 22 and 51 week feeding studies reported inhibited the development of the largest tumors (Ͼ10 mm here, and there may be mechanisms to regulate blood glycine diameter) by nearly 80%, was~65% effective on tumors from levels after prolonged periods of time (16, 18) . Second, the 5-10 mm in size, and inhibited formation of the smallest base diet used in this study (NIH-07) is different from tumors (0-5 mm) by only~23%. While dietary glycine the semi-synthetic AIN 76-based diets used previously (16) . inhibited the development of the large tumors, cell proliferation However, more interesting is the 2-3-fold increase in serum in the tumors did not differ between the WY-14,643 and WYglycine levels caused by WY-14,643 (Table II) . While reasons 14,643 ϩ glycine groups (Table IV) .
for this finding remain unknown, one possibility is that the Discussion increase in serum glycine is caused by TNFα. WY-14,643 has been shown to increase TNFα following both a single i.g. Previous studies demonstrated that dietary glycine blocked dose and 3 weeks of feeding WY-14,643 at 0.1% in the diet WY-14,643-induced increases in hepatocyte proliferation (9).
(7,9). In other studies, TNFα given as a single dose to rats caused an increase in circulating amino acids, including glycine (19) . Therefore, it is possible that the increase in serum glycine sustained hepatocyte proliferation caused by 3 weeks of feeding Cell proliferation was assessed in the normal parenchyma and in preneoplastic foci after 22 weeks of dietary treatment and in tumors after 51 weeks of treatment as described in Materials and methods. Foci and tumors were not detected in livers from control and glycine-treated animals (ND ϭ not detected). Data are reported as means Ϯ SEM for groups described in Figure 2 . a Statistical differences from control and glycine groups (ANOVA with Student-Newman-Keuls post-hoc tests; P Ͻ 0.05, n ϭ 6 in each group).
WY-14,643 in the diet (9), hyperplasia was unaffected by glycine in studies presented here (Table IV) . Based on the results of previous studies, which demonstrated that glycine prevented sustained hepatocyte proliferation and blunted hepatomegaly caused by WY-14,643 after 3 weeks (9), these findings were surprising. The mechanism by which glycine prevented the increase in cell proliferation caused by WY-14,643 in previous studies most likely involved its actions on Kupffer cells. In support of this hypothesis, inactivating Kupffer cells with methyl palmitate prior to treatment with WY-14,643 completely prevented the initial burst in hepatocyte proliferation caused by WY-14,643 (8) demonstrating that Kupffer cells are causally responsible for the stimulation in cell replication. Since antibodies to TNFα also prevented WY-14,643-stimulated cell proliferation, and inactivating Kupffer cells with methyl palmitate blocked the increase in TNFα caused by WY-14,643, Kupffer cell-derived TNFα is most likely responsible for WY-14,643-induced cell proliferation. In addition, dietary glycine also prevented WY-14,643-stimulated TNFα production and cell proliferation (7).
The mechanism by which glycine prevented Kupffer cell TNFα production is likely due to its actions on a glycine- gated chloride channel (9). Glycine binds to its receptor for development in vivo (31). Specifically, tumor growth resulting from s.c. implantation of B16 melanoma cells in vivo allowing extracellular chloride to flow into the cell causing hyperpolarization of the membrane (21) . This prevents has been shown to be dependent on vascularization of the implanted tumor (32). Treatments that inhibit tumor vascularizincreases in intracellular calcium that are required for TNFα production (21) . However, Kupffer cells isolated from rats ation also prevent tumor growth (33). In previous studies, dietary glycine blocked the formation of arteries by 70% in treated with dietary glycine (5%) for 4 weeks were not inhibited by glycine treatment in vitro and increases in intracellular B16 tumors and tumor growth was inhibited by 65% in vivo (31). However, the technique used to identify arteries in calcium were identical to controls (data not shown). This suggests that long-term dietary glycine causes down-regulation experimental mouse tumors (i.e. van Gieson's elastic stain) is not applicable in liver because only thin strands of elastin of the glycine-gated chloride channel on Kupffer cells which may explain the lack of effect of glycine on WY-14,643-fibers are present in portal triad areas instead of the thick ring present in artery walls in experimental tumors (31,34). induced cell proliferation and hepatomegaly (Figure 2 ; Table  IV) .
The mechanism by which glycine inhibited angiogenesis in experimental mouse tumors is unclear (31); however, several Fifty-one week study possibilities exist. Proliferation of endothelial cells is a key Although dietary glycine did not block WY-14,643-stimulated step in the process by which new blood vessels grow from hepatocyte proliferation (Table IV) or prevent the formation established ones (28), and glycine inhibited endothelial cell of preneoplastic foci (Table III) , it inhibited the development proliferation in vitro in a dose-dependent manner in a previous of tumors by 25-80% depending on tumor size (Figures 4 and  study (31) . Taken together, these data support the hypothesis 5). In previous tumor studies with peroxisome proliferators that dietary glycine inhibits tumor growth by preventing (22), the development of hepatocellular neoplasia was more neovascularization by inhibiting endothelial cell proliferation. sensitive than foci for detecting promoting activity. This effect Therefore, it is likely that dietary glycine inhibits WY-14,643-was explained by the observation that peroxisome proliferatorinduced hepatic cancer by preventing neovascularization and induced promotion resulted in few foci that rapidly increased suggests that glycine may be an effective anti-cancer agent. in size. Because they are present in low numbers, foci are more likely to be missed because of necessarily blind and Acknowledgements limited sampling of the entire liver. Therefore, inhibition of tumor development is a more sensitive measure of the effect Ͻ2 mm diameter (Table III) growth of mouse tumors that are dependent on vascularization
